Healthcare provider profile · identity verified

Daniel E Larkin, MD

Family Practice · SAINT PAUL, MN · NPI 1710940697

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	236	60
Atorvastatin Calcium	Atorvastatin Calcium	217	59
Rosuvastatin Calcium	Rosuvastatin Calcium	209	58
Amlodipine Besylate	Amlodipine Besylate	186	53
Shingrix	Varicella-Zoster Ge/As01b/Pf	180	134
Omeprazole	Omeprazole	165	45
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	162	162
Metoprolol Succinate	Metoprolol Succinate	129	40
Lisinopril	Lisinopril	118	33
Gabapentin	Gabapentin	116	33
Losartan Potassium	Losartan Potassium	115	37
Ozempic	Semaglutide	115	21
Metformin Hcl Er	Metformin Hcl	109	30
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	107	107
Trazodone Hcl	Trazodone Hcl	98	33
Oxycodone Hcl	Oxycodone Hcl	92	23
Spironolactone	Spironolactone	90	21
Tamsulosin Hcl	Tamsulosin Hcl	79	33
Arexvy	Rsvpref3 Antigen/As01e/Pf	78	78
Eliquis	Apixaban	77	19
Furosemide	Furosemide	76	28
Mounjaro	Tirzepatide	74	16
Clonazepam	Clonazepam	72	16
Albuterol Sulfate Hfa	Albuterol Sulfate	71	32
Pantoprazole Sodium	Pantoprazole Sodium	68	18
Bupropion Xl	Bupropion Hcl	67	16
Metformin Hcl	Metformin Hcl	67	16
Simvastatin	Simvastatin	64	19
Trulicity	Dulaglutide	62	13
Zolpidem Tartrate	Zolpidem Tartrate	62	17
Prednisone	Prednisone	61	44
Warfarin Sodium	Warfarin Sodium	60	suppressed
Allopurinol	Allopurinol	59	16
Telmisartan	Telmisartan	57	19
Cephalexin	Cephalexin	56	54
Hydrochlorothiazide	Hydrochlorothiazide	55	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	13
Lorazepam	Lorazepam	53	14
Glipizide Er	Glipizide	51	15
Alprazolam	Alprazolam	50	suppressed
Nystatin	Nystatin	47	19
Jardiance	Empagliflozin	46	13
Xarelto	Rivaroxaban	45	suppressed
Carvedilol	Carvedilol	44	14
Atenolol	Atenolol	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	27
Fluconazole	Fluconazole	42	27
Tramadol Hcl	Tramadol Hcl	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	15
Fluticasone Propionate	Fluticasone Propionate	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	34
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	14
Sertraline Hcl	Sertraline Hcl	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	13
Valacyclovir	Valacyclovir Hcl	37	13
Azithromycin	Azithromycin	34	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Rybelsus	Semaglutide	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Ketoconazole	Ketoconazole	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	28
Paxlovid	Nirmatrelvir/Ritonavir	30	29
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	22
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Famotidine	Famotidine	26	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Estradiol	Estradiol	24	suppressed
Mupirocin	Mupirocin	24	20
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Methylprednisolone	Methylprednisolone	18	16
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	18	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Terbinafine Hcl	Terbinafine Hcl	17	13
Glimepiride	Glimepiride	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Diazepam	Diazepam	15	suppressed
Lactulose	Lactulose	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Progesterone	Progesterone, Micronized	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valsartan	Valsartan	14	suppressed
Vivelle-Dot	Estradiol	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Hydrocortisone	Hydrocortisone	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Aciphex	Rabeprazole Sodium	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Maxalt Mlt	Rizatriptan Benzoate	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error